α-2-Macroglobulin in Saliva Is Associated with Glycemic Control in Patients with Type 2 Diabetes Mellitus

Table 1

Baseline demographic and clinical characteristics based on the percentage of glycosylated hemoglobin.

	HbA1c <7%; ( = 45/37.5%)	HbA1c >7%; ( = 75/62.5%)	Total; ( = 120/100%)
Male	12 (26.6%)	27 (36%)	39 (32.5%)
Age (years)	60.2 (10.2)	62.4 (10.1)	61.6 (10.1)
BMI	29.0 (4.2)	28.8 (4.5)	28.9 (4.4)
HT	29 (64)	45 (60)	74 (61.6)

BMI: body mass index; HT: hypertension; HbA1c: glycosylated hemoglobin. There were no statistically significant differences in any parameters.